The timely development of, and equitable global access to diagnostics, drugs and vaccines is a challenge not only for COVID-19, but also for other threats such as the silent pandemic of drug-resistant infections. There is an opportunity to take actions to better prepare and respond to current and future pandemics. The Graduate Institute Geneva is organizing a webinar to discuss lessons from COVID-19 for advancing antibiotic R&D.
Date: Thursday, 29 April 2021
Moderator: Suerie Moon, Co-Director, Global Health Centre, and member of DNDi‘s Board of Directors
- Manica Balasegaram, Executive Director, Global Antibiotic Research and Development Partnership (GARDP)
- Michelle Childs, Director of Policy Advocacy, Drugs for Neglected Diseases initiative (DNDi)